April 2019 - Volume 81 - Supplement 1
pp: 2-79

PDF Only


PB-1 7, 8 Dihydroxyflavone reduces mitochondrial dysregulation in the HIV-1 transgenic mouse model as a treatment for HIV associated Neurocognitive disorder (HAND)

Bryant, Joseph; Andhavarapu, Sanketh; Arvas, Muhammed Ikbal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:56, April 2019.

PC-12 Bone marrow microenvironment-induced miR-300 expression impairs natural killer cell proliferation and anti-tumor activity

Trotta, Rosanna; Silvestri, Giovannino; Stramucci, Lorenzo; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:63, April 2019.

PG-2 Evidence of increased HIV cases in greater Kinshasa urban health zones: Democratic Republic of Congo (2017–2018)

Pour, Mohammad; James, Linda; Bondo, Gaetan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:69, April 2019.

PG-4 Self-reported occupational exposure to HIV and Knowledge, Attitude to Post Exposure Prophylaxis among Health Care Workers in Federal Capital Territory, Abuja, Nigeria

Iwodi, Clementina; Olayemi, Olayemi; Adetunji, Adeyosola; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:70, April 2019.

PG-5 Assessment of knowledge, attitude and practice towards post exposure prophylaxis for HIV among health care workers in Federal Capital Territory, Abuja, Nigeria

Iowdi, Clementina; Olayemi, Olayemi; Dung, John; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:71, April 2019.

PG-9 Predictors of final HIV status outcome for HIV-exposed infants at 18 months of age in 10 Nigerian states

Adelekan, Babatunde; Harry-Erin, Abidemi; Sam-Agudu, Nadia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:74, April 2019.